Zerumbone, a Bioactive Sesquiterpene, Ameliorates Diabetes-Induced Retinal Microvascular Damage through Inhibition of Phospho-p38 Mitogen-Activated Protein Kinase and Nuclear Factor-κB Pathways
Open accessThe DOI matches its Crossref record; 38 of the 39 references it cites were found in a registry or an index.
Abstract
Zerumbone ameliorates retinal damage by blocking advanced glycation end products and their receptor system in streptozotocin-diabetic rats. Because of the multiple factors involved in diabetic retinopathy (DR) etiology, the mechanisms of zerumbone that are mainly responsible for its ameliorative effect on DR need to be further clarified. In the present study, zerumbone (20 mg or 40 mg/kg) or fenofibric acid (100 mg/kg) was orally administered to diabetic rats by intragastric gavage once daily for three consecutive months. Zerumbone displayed similar characteristics to fenofibric acid in reducing retinal vascular permeability and leukostasis in diabetic rats. Fundus photographs showed that large retinal vessel diameters were decreased in zerumbone-treated diabetic rats. Zerumbone not only down-regulated the gene expression of retinal angiogenic parameters, but also reduced the expression of inflammatory cytokines and chemokines in the retina of diabetic rats. Moreover, zerumbone reduced the p38 MAPK phosphorylation and abrogated the nuclear translocation of NF-κB p65 in the retina of diabetic rats. In conclusion, treatment of diabetic rats with zerumbone attenuates the severity of retinal inflammation and angiogenesis, via inhibition of p38 MAPK and NF-κB signaling pathways. These benefits of zerumbone for DR appear to be linked to its antihyperglycemic and antihyperlipidemic effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“and inhibition of p38 protected against diabetes-induced retinal microvascular damage in rats by a mechanism involving NFκB [ 73 ].”
From MAPK Pathways in Ocular Pathophysiology: Potential Therapeutic Drugs and Challenges (2023) · cites this paper as [73]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
Mutation of the mouse klotho gene leads to a syndrome resembling ageing
Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837
NF-κB, Inflammation, and Metabolic Disease
Baker, R. G., Hayden, M. S., & Ghosh, S. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2010.12.008 · Cited by 1,952 · cited 9×
“The expression and phosporylation of retinal IkB protein have been indicated in left pannel on Figure 6B. NF-κB p65 expression in nuclear and cytosolic fractions of retinas from rats has been shown in right pannel on Figure 6B. Data are mean ± SD from eight rats per group, and the experiments were repeated independent…”
BackgroundInfluentialEpidemiology of diabetic retinopathy, diabetic macular edema and related vision loss
Lee, R., Wong, T. Y., & Sabanayagam, C. (2015) · Eye and Vision · doi:10.1186/s40662-015-0026-2 · Cited by 1,569
How NF-κB is activated: the role of the IκB kinase (IKK) complex
Karin, M. (1999) · Oncogene · doi:10.1038/sj.onc.1203219 · Cited by 1,156
Keech, A., Mitchell, P., Summanen, P., O'Day, J., Davis, T., Moffitt, M., Taskinen, M.-R., Simes, R., Tse, D., Williamson, E., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61607-9 · Cited by 1,109 · cited 1×
“Fenofibrate is a common lipid-lowering drug and a potent agonist of the peroxisome proliferator-activated receptor α (PPARα), that has been shown to be effective in reducing the risk of progression of DR, although this effect does not seem to be attributable to changes in lipid profile [19,20].”
BackgroundDiabetic retinopathy - ocular complications of diabetes mellitus
Nentwich, M. M. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i3.489 · Cited by 553 · cited 1×
“The relative risk of developing DR is higher for type 1 diabetes compared to type 2 [1].”
BackgroundDiabetic Retinopathy: Vascular and Inflammatory Disease
Semeraro, F., Cancarini, A., dell’Omo, R., Rezzola, S., Romano, M. R., & Costagliola, C. (2015) · Journal of Diabetes Research · doi:10.1155/2015/582060 · Cited by 424 · cited 3×
“There is increasing evidence that hyperglycemia-induced inflammatory processes, including activation of inducible nitric oxide synthase (iNOS) and cyclooxygenase (COX)-2 and production of tumor necrosis factor (TNF)-α, interleukin (IL)-1β and vascular endothelial growth factor (VEGF), have a considerable role in the p…”
BackgroundInfluentialNeuroprotective and Blood-Retinal Barrier-Preserving Effects of Cannabidiol in Experimental Diabetes
El-Remessy, A. B., Al-Shabrawey, M., Khalifa, Y., Tsai, N.-T., Caldwell, R. B., & Liou, G. I. (2006) · The American Journal of Pathology · doi:10.2353/ajpath.2006.050500 · Cited by 274 · cited 1×
“In addition to NF-κB, the activation of p38 MAPK has been reported in the retinas of diabetic rats, and is associated with BRB breakdown [36].”
BackgroundSensitive blood-retinal barrier breakdown quantitation using Evans blue.
Xu, Q., Qaum, T., & Adamis, A. P. (2001) · PubMed · Cited by 274
Cited by
Bhatti, J. S., Sehrawat, A., Mishra, J., Sidhu, I. S., Navik, U., Khullar, N., Kumar, S., Bhatti, G. K., & Reddy, P. H. (2022) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2022.03.019 · Cited by 693
Involvement of Advanced Glycation End Products in the Pathogenesis of Diabetic Retinopathy
Xu, J., Chen, L.-J., Yu, J., Wang, H.-J., Zhang, F., Liu, Q., & Wu, J. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000491897 · Cited by 204
Mohamed, S. I. A., Jantan, I., & Haque, M. A. (2017) · International Immunopharmacology · doi:10.1016/j.intimp.2017.07.010 · Cited by 150
Targeting type II diabetes with plant terpenes: the new and promising antidiabetic therapeutics
Panigrahy, S. K., Bhatt, R., & Kumar, A. (2020) · Biologia · doi:10.2478/s11756-020-00575-y · Cited by 95
“It diminishes the severity of retinal inflammation and angiogenesis by inhibiting p38 MAPK and NF-kB signaling pathways (Liu et al. 2016).”
BackgroundExploring the immunomodulatory and anticancer properties of zerumbone
Haque, M. A., Jantan, I., Arshad, L., & Bukhari, S. N. A. (2017) · Food & Function · doi:10.1039/c7fo00595d · Cited by 84
Metadata
- Authors
- Liu, W., Tzeng, T.-F., & Liu, I.-M.
- Affiliations
- Jen-Ai Hospital (TW)
- Tajen University (TW)
- Corresponding author
- Liu, I-Min
- ORCID
- Liu, I-Min
- Venue
- Molecules
- Publisher
- MDPI AG
- Published
- 2016-12-11
- Volume
- 21
- Issue
- 12
- Pages
- 1708
- ISSN
- 1420-3049 (ISSN-L)
- PMC
- PMC6273957
- OpenAlex
- W2567649873
- Cited by
- 30
- References
- 39
- Citations by year
- 2024: 4 · 2023: 4 · 2022: 4 · 2021: 1 · 2020: 3 · 2019: 5 · 2018: 5 · 2017: 4
- FWCI
- 4.96
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Molecules (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Ginger and Zingiberaceae research
- Keywords
- zerumbone, sesquiterpenes, diabetic retinopathy, retinal microvascular damage, p38 MAPK, NF-κB signaling, advanced glycation end products, retinal angiogenesis, retinal inflammation, retinal vascular permeability, fenofibric acid, streptozotocin-induced diabetes, chemokines, leukostasis
- MeSH terms
- Animals, Capillary Permeability, Diabetes Mellitus, Experimental, Diabetic Retinopathy, Male, Fenofibrate, Retina, Retinal Vessels, Sesquiterpenes, Streptozocin, Signal Transduction, Glycation End Products, Advanced, Rats, Wistar, p38 Mitogen-Activated Protein Kinases, Rats, Transcription Factor RelA, Microvessels
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Zerumbone, a Bioactive Sesquiterpene, Ameliorates Diabetes-Induced Retinal Microvascular Damage through Inhibition of Phospho-p38 Mitogen-Activated Protein Kinase and Nuclear Factor-κB Pathways. https://app.cochat.ai/papers/10.3390/molecules21121708
- The paper
- Liu, W., Tzeng, T.-F., & Liu, I.-M. (2016). Zerumbone, a Bioactive Sesquiterpene, Ameliorates Diabetes-Induced Retinal Microvascular Damage through Inhibition of Phospho-p38 Mitogen-Activated Protein Kinase and Nuclear Factor-κB Pathways. Molecules. https://doi.org/10.3390/molecules21121708
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.